Literature DB >> 22129848

Depletion of alveolar macrophages prolongs survival in response to acute pneumovirus infection.

Peter Rigaux1, Kristin E Killoran, Zhijun Qiu, Helene F Rosenberg.   

Abstract

Alveolar macrophages are immunoregulatory effector cells that interact directly with respiratory virus pathogens in vivo. We examined the role of alveolar macrophages in acute infection with pneumonia virus of mice (PVM), a rodent pneumovirus that replicates the clinical sequelae of severe human respiratory syncytial virus disease. We show that PVM replicates in primary mouse macrophage culture, releasing infectious virions and proinflammatory cytokines. Alveolar macrophages isolated from PVM-infected mice express activation markers Clec43 and CD86, cytokines TNFα, IL-1, IL-6, and numerous CC and CXC chemokines. Alveolar macrophage depletion prior to PVM infection results in small but statistically significant increases in virus recovery but paradoxically prolonged survival. In parallel, macrophage depleted PVM-infected mice exhibit enhanced NK cell recruitment and increased production of IFNγ by NK, CD4(+) and CD8(+) T cells. These results suggest a protective, immunomodulatory role for IFNγ, as overproduction secondary to macrophage depletion may promote survival despite increased virus recovery. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22129848      PMCID: PMC3256929          DOI: 10.1016/j.virol.2011.10.031

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  51 in total

Review 1.  The role of scavenger receptors in the innate immune system.

Authors:  P J Gough; S Gordon
Journal:  Microbes Infect       Date:  2000-03       Impact factor: 2.700

Review 2.  Macrophage defences against respiratory tract infections.

Authors:  S B Gordon; R C Read
Journal:  Br Med Bull       Date:  2002       Impact factor: 4.291

Review 3.  Animal models of human respiratory syncytial virus disease.

Authors:  Reinout A Bem; Joseph B Domachowske; Helene F Rosenberg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-05-13       Impact factor: 5.464

4.  Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis.

Authors:  R P Garofalo; J Patti; K A Hintz; V Hill; P L Ogra; R C Welliver
Journal:  J Infect Dis       Date:  2001-07-13       Impact factor: 5.226

Review 5.  Respiratory syncytial virus disease: update on treatment and prevention.

Authors:  Leonard R Krilov
Journal:  Expert Rev Anti Infect Ther       Date:  2011-01       Impact factor: 5.091

6.  IL-12-activated NK cells reduce lung eosinophilia to the attachment protein of respiratory syncytial virus but do not enhance the severity of illness in CD8 T cell-immunodeficient conditions.

Authors:  T Hussell; P J Openshaw
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

7.  Macrophage impairment underlies airway occlusion in primary respiratory syncytial virus bronchiolitis.

Authors:  Jennifer L Reed; Yambasu A Brewah; Tracy Delaney; Timothy Welliver; Timothy Burwell; Ebony Benjamin; Ellen Kuta; Alexander Kozhich; LuAnn McKinney; JoAnn Suzich; Peter A Kiener; Luis Avendano; Luis Velozo; Alison Humbles; Robert C Welliver; Anthony J Coyle
Journal:  J Infect Dis       Date:  2008-12-15       Impact factor: 5.226

Review 8.  Respiratory syncytial virus-induced immunoprotection and immunopathology.

Authors:  Joan E Durbin; Russell K Durbin
Journal:  Viral Immunol       Date:  2004       Impact factor: 2.257

Review 9.  Interferon: cellular executioner or white knight?

Authors:  S G Maher; A L Romero-Weaver; A J Scarzello; A M Gamero
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

10.  Clearance of influenza virus from the lung depends on migratory langerin+CD11b- but not plasmacytoid dendritic cells.

Authors:  Corine H GeurtsvanKessel; Monique A M Willart; Leonie S van Rijt; Femke Muskens; Mirjam Kool; Chantal Baas; Kris Thielemans; Clare Bennett; Björn E Clausen; Henk C Hoogsteden; Albert D M E Osterhaus; Guus F Rimmelzwaan; Bart N Lambrecht
Journal:  J Exp Med       Date:  2008-07-07       Impact factor: 14.307

View more
  14 in total

1.  Critical Adverse Impact of IL-6 in Acute Pneumovirus Infection.

Authors:  Caroline M Percopo; Michelle Ma; Todd A Brenner; Julia O Krumholz; Timothy J Break; Karen Laky; Helene F Rosenberg
Journal:  J Immunol       Date:  2018-12-21       Impact factor: 5.422

2.  A gammaherpesvirus licenses CD8 T cells to protect the host from pneumovirus-induced immunopathologies.

Authors:  Bénédicte Machiels; Laurent Gillet; Mickaël Dourcy; Céline Maquet; Lorène Dams; Gautier Gilliaux; Justine Javaux; Daniel Desmecht; Matthias Mack; Benjamin G Dewals
Journal:  Mucosal Immunol       Date:  2020-05-18       Impact factor: 7.313

3.  Dual effects of respiratory syncytial virus infections on airway inflammation by regulation of Th17/Treg responses in ovalbumin-challenged mice.

Authors:  Jia Wang; Lingwen Kong; Qingli Luo; Bei Li; Jinfeng Wu; Baojun Liu; Xiao Wu; Jingcheng Dong
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

4.  Priming of the Respiratory Tract with Immunobiotic Lactobacillus plantarum Limits Infection of Alveolar Macrophages with Recombinant Pneumonia Virus of Mice (rK2-PVM).

Authors:  Kimberly D Dyer; Rebecca A Drummond; Tyler A Rice; Caroline M Percopo; Todd A Brenner; Derek A G Barisas; Kendal A Karpe; Martin L Moore; Helene F Rosenberg
Journal:  J Virol       Date:  2015-11-04       Impact factor: 5.103

5.  Characterization of the resistance of SJL/J mice to pneumonia virus of mice, a model for infantile bronchiolitis due to a respiratory syncytial virus.

Authors:  Stephanie Glineur; Dao Bui Tran Anh; Michaël Sarlet; Charles Michaux; Daniel Desmecht
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

Review 6.  Apoptosis in pneumovirus infection.

Authors:  Elske van den Berg; Job B M van Woensel; Reinout A Bem
Journal:  Viruses       Date:  2013-01-23       Impact factor: 5.048

7.  Innate and adaptive immune response to pneumonia virus of mice in a resistant and a susceptible mouse strain.

Authors:  Ellen R T Watkiss; Pratima Shrivastava; Natasa Arsic; Susantha Gomis; Sylvia van Drunen Littel-van den Hurk
Journal:  Viruses       Date:  2013-01-21       Impact factor: 5.048

Review 8.  The Pneumonia Virus of Mice (PVM) model of acute respiratory infection.

Authors:  Kimberly D Dyer; Katia E Garcia-Crespo; Stephanie Glineur; Joseph B Domachowske; Helene F Rosenberg
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

9.  Boron Induces Lymphocyte Proliferation and Modulates the Priming Effects of Lipopolysaccharide on Macrophages.

Authors:  Indusmita Routray; Shakir Ali
Journal:  PLoS One       Date:  2016-03-02       Impact factor: 3.240

10.  Rhinovirus Reduces the Severity of Subsequent Respiratory Viral Infections by Interferon-Dependent and -Independent Mechanisms.

Authors:  James T Van Leuven; Andres J Gonzalez; Emmanuel C Ijezie; Alexander Q Wixom; John L Clary; Maricris N Naranjo; Benjamin J Ridenhour; Craig R Miller; Tanya A Miura
Journal:  mSphere       Date:  2021-06-23       Impact factor: 4.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.